Valuation : Amarin Corporation plc

Market Cap 297M 255M 239M 219M 412M 28.38B 413M 2.83B 1.11B 14.31B 1.12B 1.09B 47.35B P/E 2026 *
-201x
P/E 2027 * -235x
Enterprise Value 135M 116M 108M 99.29M 187M 12.89B 188M 1.28B 502M 6.49B 507M 496M 21.49B EV / Sales 2026 *
0.76x
EV / Sales 2027 * 0.69x
Free-Float
86.93%
Yield 2026 *
-
Yield 2027 * -
1 day-2.12%
1 week+0.07%
Current month-1.33%
1 month+1.88%
3 months-3.10%
6 months+1.96%
Current year+0.82%
1 week 13.8
Extreme 13.8
15.24
1 month 13.76
Extreme 13.76
15.24
Current year 12.96
Extreme 12.96
17.31
1 year 12.96
Extreme 12.96
20.9
3 years 7.08
Extreme 7.08
27.4
5 years 7.08
Extreme 7.08
113.5
10 years 7.08
Extreme 7.08
522.4
Manager TitleAgeSince
Chief Executive Officer 63 2024-06-03
Director of Finance/CFO 42 2024-10-22
Compliance Officer 56 2023-11-14
Director TitleAgeSince
Director/Board Member 63 2024-06-03
Director/Board Member 43 2023-02-27
Director/Board Member 67 2023-02-27
Date Insider Type Main position Quantity % Market Cap.
8/1/26 Fiscal year

Chief Financial Officer

781 0.0002%
7/1/26 Fiscal year

Chief Operating Officer

9,302 0.0022%
7/1/26 Fiscal year

Chief Technology Officer

9,263 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
-2.12%+0.07%-9.05%-30.35% 297M
+3.31%-3.70%+61.03%+103.64% 70.64B
+1.09%+2.51%+49.34%+93.39% 66.11B
-1.03%+0.46%+8.14%-5.28% 27.98B
-2.41%-2.95%-9.77%+455.82% 26.51B
+0.40%-0.59%+63.34%+12.04% 26.44B
+1.02%+6.43%+269.42%+420.34% 20.4B
+0.37%+1.21%+36.55%-15.78% 20.17B
-2.00%-4.83%+12.78%+528.22% 15.99B
-1.50%+2.92%+43.50%+151.30% 13.69B
Average -0.33%+0.90%+52.53%+171.33% 28.82B
Weighted average by Cap. +0.67%+0.65%+56.37%+154.45%

Financials

2026 *2027 *
Net sales 177M 152M 143M 131M 246M 16.95B 247M 1.69B 660M 8.54B 666M 652M 28.27B 177M 152M 142M 130M 245M 16.89B 246M 1.68B 658M 8.51B 664M 650M 28.17B
Net income -26.62M -22.85M -21.4M -19.59M -36.91M -2.54B -37.01M -253M -99.04M -1.28B -99.96M -97.8M -4.24B -18.32M -15.73M -14.72M -13.48M -25.4M -1.75B -25.47M -174M -68.15M -882M -68.78M -67.29M -2.92B
Net Debt -162M -139M -130M -119M -225M -15.5B -226M -1.54B -604M -7.81B -609M -596M -25.85B -175M -150M -141M -129M -242M -16.7B -243M -1.66B -651M -8.42B -657M -642M -27.86B
Logo Amarin Corporation plc
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Employees
80
Date Price Change Volume
26-08-27 $14.07 -2.12% 83,426
26-08-26 $14.38 +1.59% 159,429
26-08-25 $14.15 +2.24% 505,372
26-08-24 $13.84 -1.77% 106,412
26-08-21 $14.09 +0.21% 36,563
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
2
Last Close Price
14.07USD
Average target price
12.50USD
Spread / Average Target
-11.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRN Stock